On March 4, 2022, Mr. Brandon Thall tendered his resignation as Chief Financial Officer of Selectis Health, Inc. (the “Company”), effective immediately. Christine Lucus, formerly serving as Controller, has been appointed interim CFO of the Company effective March 4, 2022. Christine Lucus, age 32, joined the Company in April, 2021 as the Controller.

Mrs. Lucus has spent her career in the pharmaceutical industry. Prior to joining the Company, she was the Controller for Neubase Therapeutics, Inc.